Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsGeorge D. Demetri, Heikki Joensuu|New England Journal of Medicine|2002Cited by 4.4k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialWinette T.A. van der Graaf, Peter Hohenberger, Jean‐Yves Blay et al.|The Lancet|2012Cited by 2.1k
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trialGeorge D. Demetri, Paolo G. Casali, Peter Reichardt et al.|The Lancet|2012Cited by 1.4k
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal TumorsGeorge D. Demetri, Jeffrey D. Wayne, Margaret von Mehren et al.|Journal of the National Comprehensive Cancer Network|2010Cited by 1.2k
High-throughput oncogene mutation profiling in human cancerRoman K. Thomas, Meenhard Herlyn, Stan F. Nelson et al.|Nature Genetics|2007Cited by 996